Search

Your search keyword '"Pollara, Justin"' showing total 336 results

Search Constraints

Start Over You searched for: Author "Pollara, Justin" Remove constraint Author: "Pollara, Justin"
336 results on '"Pollara, Justin"'

Search Results

3. Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques

6. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1

8. Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.

10. Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing

11. Oncolytic Adenovirus Mem-288 Encoding Membrane-Stable Cd40l and Ifnβ Induces an Anti-Tumor Immune Response in High Grade Serous Ovarian Cancer

12. Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques

13. Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model

14. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

15. In utero human cytomegalovirus infection expands NK cell-like FcγRIII-expressing CD8+ T cells that mediate antibody-dependent functions

17. Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses than that of the Partially Effective gB/MF59 Vaccine

20. Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection

23. 7/#178 Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFN beta induces an anti-tumor immune response in a high grade serous ovarian cancer mouse model

25. Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

26. Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses

27. Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation

28. Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques

29. Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus

31. Dual-affinity re-targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

32. Elite neutralizers of human cytomegalovirus are characterized by high magnitude plasma IgG responses against multiple glycoprotein complexes

33. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life

34. Early post-vaccination gene signatures correlate with the magnitude and function of vaccine-induced HIV envelope-specific plasma antibodies in infant rhesus macaques

35. Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques

36. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

37. Additional file 1 of Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy

38. Development of flow cytometry‐based assays to assess the ability of antibodies to bind to SARS‐CoV ‐2‐infected and Spike‐transfected cells and mediate NK cell degranulation

39. Two Compartment Evaluation of Liver Grafts During Acellular Room Temperature Machine Perfusion (acRTMP) in a Rat Liver Transplant Model

40. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection

41. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies

42. Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

43. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

44. Vaccine-induced, high magnitude HIV Env-specific antibodies with Fc-mediated effector functions are insufficient to protect infant rhesus macaques against oral SHIV infection

46. A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates

48. HIV-1 VACCINES: Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

49. Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission

50. Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques

Catalog

Books, media, physical & digital resources